mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.09 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.09 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.09 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.09 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.1 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |